Mark is one of the Founders and Managing Partners at Axian.  After doing a degree in Marine Biology followed by a Physiology Ph.D., he moved into clinical development roles in industry before becoming an internal consultant working on process transformations and the two mergers that created GSK. He then moved into consulting and has supported many clients to achieve the changes they need across clinical, medical affairs and particularly pharmacovigilance functions.

He is an enthusiastic proponent of proactive PV and the potential of digital engagement to transform the effectiveness risk management activities and hence improve patient safety.

Outside of work he’s frequently to be found working on home or garden and less often running around the local lanes or diving in the chilly but often spectacular waters of South West England.